Perspective Therapeutics Inc (CATX)
2.64
-0.07
(-2.58%)
USD |
NYAM |
Oct 09, 13:49
Perspective Therapeutics Profit Margin (Quarterly) : -33.31K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -33.31K% |
| March 31, 2026 | -34.46K% |
| December 31, 2025 | -87.19K% |
| September 30, 2025 | -12.43K% |
| June 30, 2025 | -7.59K% |
| March 31, 2025 | -5.31K% |
| December 31, 2024 | -17.14K% |
| September 30, 2024 | -4.10K% |
| June 30, 2024 | -2.14K% |
| March 31, 2024 | -3.64K% |
| September 30, 2023 | -3.47K% |
| June 30, 2023 | -1.61K% |
| March 31, 2023 | |
| June 30, 2022 | -82.95% |
| March 31, 2022 | -46.29% |
| December 31, 2021 | -56.96% |
| September 30, 2021 | -87.48% |
| June 30, 2021 | -39.15% |
| March 31, 2021 | -28.65% |
| December 31, 2020 | -36.80% |
| September 30, 2020 | -29.91% |
| June 30, 2020 | -52.13% |
| March 31, 2020 | -18.92% |
| December 31, 2019 | -40.66% |
| September 30, 2019 | -35.25% |
| Date | Value |
|---|---|
| June 30, 2019 | -56.91% |
| March 31, 2019 | -58.58% |
| December 31, 2018 | -74.26% |
| September 30, 2018 | -96.54% |
| June 30, 2018 | -147.1% |
| March 31, 2018 | -84.68% |
| December 31, 2017 | -95.25% |
| September 30, 2017 | -127.7% |
| June 30, 2017 | -135.3% |
| March 31, 2017 | -106.1% |
| December 31, 2016 | -141.1% |
| September 30, 2016 | -138.6% |
| June 30, 2016 | -105.8% |
| March 31, 2016 | -99.72% |
| December 31, 2015 | -110.3% |
| September 30, 2015 | -80.80% |
| June 30, 2015 | -77.18% |
| March 31, 2015 | -82.34% |
| December 31, 2014 | -85.12% |
| September 30, 2014 | -75.42% |
| June 30, 2014 | -176.7% |
| March 31, 2014 | -183.7% |
| December 31, 2013 | -85.41% |
| September 30, 2013 | -121.0% |
| June 30, 2013 | -79.99% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 3.72% |
| Rigel Pharmaceuticals, Inc. | 21.97% |
| Enanta Pharmaceuticals, Inc. | -135.8% |
| Insight Molecular Diagnostics, Inc. | -4.71K% |
| BridgeBio Pharma, Inc. | -63.97% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.07% |
| Return on Assets | -34.66% |
| Return on Invested Capital | -41.52% |
| Gross Profit Margin (Quarterly) | -1.31K% |
| Operating Margin (Quarterly) | -36.12K% |
| Return on Net Operating Assets | -91.31% |